---
$id: https://graph.org.ai/products/commodity/51241252
$type: Product
source: UNSPSC
code: "51241252"
title: "Pidobenzone"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pidobenzone

**UNSPSC Code**: 51241252
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an agent affecting integumentary system with the molecular formula C11H11NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X7D2GSX1C1, chemically known as 5-oxo-l-proline, p-hydroxyphenyl ester but generally known as pidobenzone, which bears US NIH Compound Identifier 3047843. European Medicines Agency schedules Pidobenzone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09823MIG. The term PIDOBENZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). PIDOBENZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pidobenzone under HS 29337900 and SITC 51561. As of Q4 2014, PIDOBENZONE remains the US FDA Preferred Term for this commodity. Pidobenzone bears US NLM identifiers UMLS ID C2604951 and NCI Concept Code C76886. SMILES: C1CC(=O)NC1C(=O)OC2=CC=C(C=C2)O.

